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ABSTRACT
Introduction Self- harm and suicidal behaviour represent 
major global health problems, which account for significant 
proportions of the disease burden in low- income and 
middle- income countries, including Ghana. This review 
aims to synthesise the available and accessible evidence 
on prevalence estimates, correlates, risk and protective 
factors, the commonly reported methods and reasons for 
self- harm and suicidal behaviour in Ghana.
Methods and analysis We will conduct a systematic 
review reported according to the Preferred Reporting Items 
for Systematic Reviews and Meta- Analyses statement 
(2009) recommendations. Regional and global electronic 
databases (African Journals OnLine, African Index Medicus, 
APA PsycINFO, Global Health, MEDLINE and PubMed) 
will be searched systematically up to December 2021 
for observational studies and qualitative studies that 
have reported prevalence estimates, correlates, risk and 
protective factors, methods and reasons for self- harm 
and suicidal behaviour in Ghana. The electronic database 
searches will be supplemented with reference harvesting 
and grey literature searching in Google Scholar and 
ProQuest Dissertations & Theses Global for postgraduate 
dissertations. Only records in English will be included. 
The Mixed Methods Appraisal Tool (2018) will be used 
to assess the methodological quality of included studies. 
Meta- analysis or narrative synthesis or both will be used, 
contingent on the extent of heterogeneity across eligible 
observational studies.
Ethics and dissemination Considering that this is a 
systematic review of accessible and available literature, 
we will not seek ethical approval. On completion, this 
review will be submitted to a peer- reviewed journal, be 
disseminated publicly at (mental) health conferences 
with focus on self- harm and suicide prevention. The 
important findings would also be shared with key national 
stakeholder groups in Ghana: Ghana Association for 
Suicide Prevention, Ghana Mental Health Authority, Ghana 
Psychological Association, Centre for Suicide and Violence 
Research, Accra and the Parliamentary Select Committee 
on Health.
Prospero registration number CRD42021234622.
INTRODUCTION
According to the WHO, self- harm (‘inten-
tional self- inflicted poisoning or injury, 
which may or may not have a fatal intent or 
outcome’)1 and suicidal behaviour (‘a range 
of behaviours that include thinking about 
suicide (or ideation), planning for suicide, 
attempting suicide and suicide itself’)2 
represent major global health problems 
that account for significant proportions of 
the global disease burden annually, partic-
ularly, in low and middle- income countries 
(LAMICs), including Ghana.3 In 2016, self- 
harm was ranked among the top 12 causes 
of death among persons aged 10–24 years in 
sub- Saharan Africa,4 and about 77% of global 
suicides in 2019 were recorded in LAMICs.5
Nonetheless, as observed in some LAMICs,6 
attempted suicide is still a crime and remains 
highly stigmatised in Ghana,7 8 Section 57:1 
of Ghana’s Criminal Code provides that 
‘a person who attempts to commit suicide 
commits a misdemeanour’,7 but there are 
growing efforts by various stakeholder groups 
and organisations in the country towards 
getting the Parliament of Ghana to consider 
repealing the antisuicide law. To date, only 
one national- level systematic review on 
‘mental health research in Ghana’, published 
nearly a decade ago, is available,9 but without 
specific primary focus on self- harm or suicidal 
behaviour in the country. Also, two recent 
Strengths and limitations of this study
 ► This is the first country- level systematic review of 
the prevalence, correlates, risk and protective fac-
tors, methods and reported reasons for self- harm 
and suicidal behaviour in Ghana.
 ► This protocol has been reported in accordance with 
the Preferred Reporting Items for Systematic Review 
and Meta- Analysis (PRISMA) Protocol guidelines.
 ► A senior information specialist will contribute to 
the development of the search strategies to ensure 
specificity, sensitivity and replication across all se-
lected databases.
 ► On completion, the review will be reported accord-
ing to the recommendations of the PRISMA- 2009 
statement.
 ► The criminal status of attempted suicide in Ghana 
and the lack of routinely collected data on (attempt-
ed) suicide in the country are likely to limit the key 
findings of this review.
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regional systematic reviews related to self- harm among 
young people10 and suicide in the general adult popula-
tion11 have included data from Ghana. Even though these 
two regional reviews posit self- harm and suicidal behaviour 
as possible important public health challenges in Ghana, 
none of them provides a relatively whole picture of the 
phenomena within and across the general population of 
the country exclusively in one report. This is the gap in 
knowledge that the current review seeks to contribute 
evidence to address. Notably, emerging evidence suggests 
that Ghana is showing potential in the contribution of 
published literature on the phenomena of self- harm and 
suicidal behaviour.10 11
Thus, it is timely to consider performing a systematic 
review that integrates and synthesises the evidence exclu-
sively from Ghana on self- harm and suicidal behaviour. 
Potentially, the body of evidence from a carefully planned 
and performed country- level systematic review will, in 
part, better inform the ongoing (de)criminalisation 
debates and antistigma campaigns and provide a research- 
informed basis for the development of contextually rele-
vant and culturally sensitive intervention and prevention 
programmes in the country. Also, a country- level system-
atic review of the current nature can be informative in 
mapping out areas of self- harm and suicidal behaviour 
that require initial or expansive research attention.
Ghana is an Anglophone West African country with 
an estimated population of 30.9 million.12 The country 
is heterogeneous regarding ethnic groupings, language 
and religion. About 71.2% of Ghanaians identify as 
Christians, 17.6% as Muslims, 5.2% as African Tradi-
tional Religion adherents and 5.3% without any reli-
gious affiliation.13 The country is categorised as having 
a medium human development index (rank of 138), 
with a life expectancy of 64.1 years as of 2019.14 It is a 
lower middle- income country.15 In terms of the sustain-
able development goals, Ghana has an index score of 
65.4%, with a global ranking of 100 out of 166 countries. 
Ghana has the most comprehensive mental health legis-
lation across Anglophone West Africa,16 17 but there are 
still fundamental challenges with implementation, nega-
tive public attitudes and access. For example, the three 
psychiatric hospitals in the country are all located within 
two regions in the south—out of the 16 regions of the 
country; only 2.8% of persons requiring mental health 
services are able to access professional care.18 The most 
recent crude estimate by the WHO indicates that 6.6/100 
000 population (women=177; men=1816) died by suicide 
in Ghana during 2019.5 The country is generally faced 
with an acute shortage of mental health professionals, 
and mental health facilities and services are significantly 
underfunded.18–20 In Ghana, the psychiatrist to popu-
lation ratio is 0.058 per 100 000 population, and 0.065 
psychologists per 100 000 population—which is less than 
enough compared with the WHO benchmark of one 
psychiatrist/100 000 population.21
Prior to designing and developing this review protocol, 
we searched key systematic review repositories and 
protocol registers, including the International Prospec-
tive Register of Systematic Reviews (PROSPERO), the 
Cochrane Library, Joanna Briggs Institute Database of 
Systematic Reviews and Implementation Reports and the 
Campbell Collaboration. We also searched peer- reviewed 
journals such as BMJ Open and BMC Systematic Reviews, and 
the key electronic databases selected for this review, to 
identify same or similarly worded—recently—published 
prospective or completed systematic reviews, specifically 
on self- harm and suicidal behaviour in Ghana. However, 
we found no such (prospective or completed) reviews; 
thus, no national- level systematic review exclusively 
focused on self- harm and suicidal behaviour in Ghana has 
been published.
Objectives
The objectives of this review will be to:
 ► Describe the reported prevalence estimates of self- 
harm and suicidal behaviour (ideation, planning and 
attempt) in Ghana.
 ► Describe the methods and means of self- harm and 
suicide attempt that have been reported in Ghana.
 ► Examine the reported motivations/reasons for self- 
harm in Ghana.
 ► Identify the known common correlates, risk and 
protective factors and associated key sociodemo-
graphic factors of self- harm and suicidal behaviour 
(ideation, planning and attempt) in Ghana.
METHODS
The development of this systematic review protocol 
is being reported in accordance with the Preferred 
Reporting Items for Systematic Review and Meta- Analysis 
(PRISMA) Protocol guidelines.22 Notably, on completion, 
the reporting of this systematic review will be guided by 
the community- agreed statement of the PRISMA- 2009.23 
The title and key information about the design and 
methods of this proposed systematic review have been 
registered on the PROSPERO database.
Eligibility criteria
Table 1 summarises the inclusion and exclusion criteria 
that will guide the selection of potentially eligible records.
Outcomes
Potentially eligible studies must have assessed or 
measured self- harm or suicidal behaviour (ideation, 
planning or attempt) as outcome in any age group in 
Ghana. Considering the criminal status of attempted 
suicide in Ghana and the lack of routinely collected offi-
cial data on suicide in the country, we anticipate that 
eligible prevalence studies on suicidal deaths—where 
available—are likely to be based on medicolegal autopsy 
studies or police records, which are often less reflective 
of the true scope of the problem in the general popula-
tion.24 Specifically, eligible studies must report evidence 
that addresses at least one of the objectives of this review: 
(a) reported period prevalence (lifetime, 12- month, 
6- month or 1- month) estimates of self- harm and suicidal 
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behaviour in Ghana, (b) methods and means of self- harm 
and suicide in Ghana, (c) motivations/reasons for self- 
harm in Ghana and (d) correlates, risk and protective 
factors and key sociodemographic factors associated with 
self- harm and suicidal behaviour in Ghana. Potentially 
eligible studies estimating the prevalence of self- harm or 
suicidal behaviour must have specified the time frame or 
period of prevalence and clearly identified their method 
of assessment. Eligible prevalence studies will be consid-
ered for inclusion if they have a clear indication of the 
sample size and population denominator. Clinic- based 
(accident and emergency/outpatient/inpatient depart-
ment) prevalence studies will be excluded due to the 
inherent bias in selection of patients and patients’ access 
to clinical care that could skew results artificially.25 26 For 
the same reason, studies reporting evidence of prevalence 
based on medicolegal autopsy studies or police records 
will be excluded.24 27
Definition and measurement of outcomes
Studies with clear definitions of self- harm or suicidal 
behaviour (ideation, planning and attempt) will be 
considered for inclusion. Although we anticipate eligible 
studies to distinguish between suicidal self- harm and 
non- suicidal self- harm in their findings, we are mindful 
to include all acts that meet the WHO definition of self- 
harm applied in this review—which does not require a 
specific intent.1 28 We will adopt this position because the 
literature is replete with debates about the clarity and 
usefulness (or otherwise) of the distinction between self- 
reported suicidal and non- suicidal acts of self- harm,29 
which can be particularly problematic in a country like 
Table 1 Summary of inclusion and exclusion criteria
Criterion Include Exclude
Setting  ► Primary studies conducted within non- clinical 
contexts (ie, general population, community, 
school- based, households/neighbourhoods, 
homeless context, street- connected settings, 
correctional facilities etc.) in Ghana.
 ► Clinic- based studies conducted in Ghana 
focused on self- harm or suicidal behaviour as the 
main presenting condition.
 ► Studies focused on self- harm or suicidal 
behaviour, but participants selected from a 
geographical context outside Ghana.
Participants  ► Participants sampled from Ghana regardless 
of age, gender, sexual or gender orientation, 
occupational group, religious groupings, health 
status, or ‘alternative’ subcultures (eg, cult 
groups, Goth, Emo, Metallers, Punk).
 ► Participants in eligible studies who have had 
personal experiences of self- harm or suicidal 
behaviour.
 ► Cross- national studies involving Ghana but with 
study results not disaggregated by country.
 ► Studies involving participants who report no 
personal experience of self- harm or suicidal 
behaviour.
Study designs  ► Primary studies with focus on self- harm or 
suicidal behaviour which address at least one 
of the four specified objectives of this review 
using observational study designs or qualitative 
approaches.
 ► Publications/reports in English language.
 ► Peer- reviewed publications, unpublished records 
based on data, preprints, and postgraduate 
theses.
 ► Systematic reviews
 ► Studies based on the same dataset reported in an 
earlier publication included in this review.
 ► Full text of identified records unavailable or 
inaccessible, even after contacting authors.
 ► Non- English language records.
 ► Grey literature such as undergraduate theses, 
editorials, commentaries, opinion pieces, 
correspondence and articles not based on data.
Prevalence 
estimate
 ► Studies must specify time frames within which 
prevalence of self- harm and/or suicidal behaviour 
was assessed.
 ► Time frame of prevalence estimates cannot be 
determined, even after contacting authors.
 ► Study reports with no clear indication of sample 
size and population denominator.
Definition and 
measurement of 
self- harm and/or 
suicidal behaviour
 ► Studies with clear definitions of self- harm 
and (specific) suicidal behaviour, in addition 
to specific measurement, means of case 
identification, or assessment.Only self- reported 
prevalence estimates of outcomes will be 
considered for inclusion.
 ► Studies focused on intentional self- harm with 
socially sanctioned motives (eg, religious fasting, 
manhood rituals, scarification (tribal marks), ‘body 
enhancement’, hunger strikes etc.).
 ► Studies with focus on unintentional self- harm 
behaviours (eg, eating disorders, smoking, drink- 
driving, etc.).
 ► Studies focused on unintentional injuries, suicide 
bombing, or euthanasia/mercy killing.
 ► Prevalence studies based on family reports.
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Ghana, where attempted suicide is a crime and where 
different languages may not clearly reflect the distinc-
tion.7 30 Furthermore, we will include all acts that meet the 
WHO definition of self- harm applied in this review, as all 
acts of self- harm (regardless of attribution and intention) 
are associated with increased risk of death by suicide.1 2 30 
Thus, we will include all studies where it is clear that self- 
harm (regardless of apparent intent), suicidal ideation, 
suicidal planning or attempted suicide was the question 
that participants were asked.
Additionally, specific measurement or means of case 
identification/assessment (including self- report measures 
or diagnostic instruments) should have been reported by 
potentially eligible studies:
 ► assessment using a standardised clinician rating based 
on medical documentation or clinical interview.
 ► Clinic- based diagnostic case ascertainment at admis-
sion or by inspecting medical records, clinical chart 
reviews or other.
 ► Assessment based on interviews that were constructed 
ad hoc for the study or interviews for which validation 
data are available.
 ► Assessment by a self- report single item.
 ► Assessment by a self- report multiitem questionnaire 
for which validation data or psychometric informa-
tion are available or unavailable.
Prevalence studies that access data from family will be 
excluded: only self- reported estimates will be considered 
for inclusion.
Types of study
This review will consider for inclusion primary studies that 
have used observational study designs (ie, cross- sectional 
studies, case–control studies and cohort studies).31 32 
Evidence on prevalence estimates and associated factors 
of self- harm and suicidal behaviour (ideation, planning 
and attempt) will be drawn mainly from the eligible 
observational studies. Primary studies using qualitative 
methods (eg, interviews, focus groups, psychological 
autopsy studies, media content analyses, retrospective 
analyses of clinical records) will be considered for inclu-
sion to provide evidence, mainly, on the reported moti-
vations/reasons and methods/means of self- harm and 
attempted suicide. Besides elaborating self- reported 
motivations/reasons for self- harm and suicidal behaviour, 
eligible qualitative studies may also shed additional light 
on the roles that specific correlates, risks and protective 
factors play in relation to self- harm and attempted suicide. 
A study will be excluded if the data had been reported (in 
a relatively sufficient detail, including larger sample size) 
by an earlier or recent study based on the same data set. 
Peer- reviewed publications based on postgraduate theses 
will be considered for inclusion, but the theses will be 
consulted for further methodological details.
Participants
This review will consider for inclusion studies that involve 
children, adolescents and adults, regardless of gender, 
sexual orientation, occupational group or religious 
groupings sampled from Ghana. Participants in eligible 
studies must have had personal experiences of self- harm 
or suicidal behaviour (ideation, planning and attempt).
Study setting
This review will include studies conducted in Ghana or 
within any of its 16 administrative geographical regions. 
Specifically, potentially eligible studies must have been 
conducted within clinical or non- clinical contexts, 
including schools, households, community, homeless 
contexts, street- connected settings, rural, periurban or 
urban settings.
Information sources
We will develop search strategies for eligible literature 
using medical subject headings (MeSH) and text words 
related to self- harm, suicidal behaviour and Ghana. We 
will search six electronic databases: two regional- specific 
databases (African Journals OnLine (AJOL) and African 
Index Medicus (AIM)) and four global databases (APA 
PsycINFO, Global Health, MEDLINE and PubMed). The 
electronic database search will be supplemented with grey 
literature (ie, postgraduate dissertations and preprints). 
We will search ProQuest Dissertations & Theses Global, 
and Google Scholar for postgraduate dissertations. For 
preprints, we will search the Social Science Research 
Network, medRxiv, Research Square and Open Science 
Framework. Additionally, we would search the references 
of key papers to harvest or chase the citations of poten-
tially eligible papers; we would use Social Science Cita-
tion Index, Science Citation Index and Google Scholar 
(‘Cited by’ function) to search relevant forward citations 
of key papers. Beyond the database searching, we will 
contact authors of at least two eligible papers, requesting 
for copies of relevant unpublished papers from their 
personal records to be screened for inclusion. We will use 
the ‘Similar articles’ feature in PubMed and the ‘Related 
articles’ function in Google Scholar to locate additional 
studies. All searches will be limited to studies reported 
in English and involving human subjects. English is the 
formal language of Ghana and scientific works from the 
country are published in English. The anticipated comple-
tion date of this review is March 2022. Thus, the searches 
will be limited to the year of inception of the selected 
databases, first, up to December 2020, then updated to 
December 2021, towards the end of the review.
Search strategy and process
Our specific literature search strategies will be created 
with the assistance of a senior information specialist 
with expertise in systematic review searching on health 
topics related to LAMICs. Our search strategy would 
include keywords, truncation, Boolean logic operators 
(AND, OR, NOT) and MeSH terms as relevant to and 
appropriate for each selected database (eg, (self- harm 
OR self- poisoning OR self- injur* OR attempted suicide 
OR suicid*) AND (Ghana OR Accra OR Kumasi OR 
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Tamale)). The geographic search filter would include 
‘Ghana’ and names of the 16 regions and capital cities; 
these would include both earlier and current names. After 
a prototype, APA PsycINFO search strategy is developed 
and finalised, it will be adapted to the subject headings 
and syntax of the other databases (AJOL, AIM, Global 
Health, MEDLINE and PubMed). The APA PsycINFO 
search strategy will be developed first with input from 
the review team and then peer reviewed by the senior 
information specialist providing technical advice for this 
review. Appendix 1 shows the draft APA PsycINFO search 
strategy. The reporting of our searches will be guided 
by the Statement for Reporting Literature Searches in 
Systematic Reviews (PRISMA- S).33 Three authors (EN- 
BQ, KOA and JA- A) will run the searches and one author 




EndNote (V.X9.3.3) will be used to collate, handle and 
manage the results of the database searches, to remove 
duplicates of records and to access the full text of poten-
tially eligible studies. Notably, the selected databases will 
be searched individually, but the results will be combined 
before removing duplicates.
Selection process
Two reviewers (KOA and JA- A) will independently screen 
the titles and abstracts of the identified records within the 
lens of the prespecified eligibility criteria. We will then 
screen the full text of potentially eligible studies for inclu-
sion, also guided by our prespecified eligibility criteria for 
the review. We will refer to published protocols of eligible 
studies and associated online supplemental materials or 
contact authors of eligible studies (that are not available 
online) through telephone or email correspondence for 
additional relevant information or missing information, 
where the authors are unable to reach consensus, the 
specific papers will be referred to a third reviewer (EN- 
BQ) for resolution.
Data collection process and data items
We will design an extraction form to record relevant 
information from eligible studies. The extraction form 
will include information about authors, year of publica-
tion, setting of study (clinic- based or non- clinical, etc), 
sampling and sample size, study design, outcome measure-
ment, key findings and study quality score. Following the 
definitions and nomenclature of self- harm and suicidal 
behaviour guiding, this systematic review, the extraction 
of information on self- harm, will include self- poisoning 
and self- injury; and suicidal behaviour will include suicidal 
ideation, suicidal planning, suicidal attempt and suicide. 
Two reviewers (KOA and JA- A) will independently extract 
data from the included studies and the extractions will 
be referred to a third reviewer (ENBQ) for complete-
ness and accuracy check. The review team will resolve 
discrepancies through consensus for accuracy check of 
included studies. We will also contact study authors of 
eligible studies for additional information and accuracy 
check—where necessary—to resolve uncertainties.
Risk of bias in individual studies
Two reviewers would independently use the Mixed 
Methods Appraisal Tool (MMAT- 2018).34 35 The MMAT- 
2018 is robust for assessing and describing the meth-
odological quality of different kinds of study designs: 
qualitative research, randomised controlled trials, non- 
randomised studies, quantitative descriptive studies and 
mixed method studies.34–36 The MMAT- 2018 has three 
reviewer rating options: ‘yes’ (there is clear information 
related to the criterion), ‘no’ (there is no information 
related to the criterion), or ‘can’t tell’ (reported informa-
tion related to the criterion is unclear or inappropriate). 
Where reviewers are unclear (can’t tell), authors will be 
contacted for clarification. No study will be excluded 
based on quality rating.
Data synthesis
Meta- analysis or narrative synthesis or both will be used, 
contingent on the extent of heterogeneity across the 
eligible observational studies (reporting prevalence and 
associations). The I2 statistic would be used to assess the 
extent of heterogeneity across the eligible prevalence and 
association studies (I2 value of zero=no heterogeneity; 
≤25%=low heterogeneity; 50%=moderate heterogeneity 
and ≥75% = substantial heterogeneity).37–39 If zero or low 
heterogeneity is obtained, the prevalence estimates would 
be pooled in meta- analysis based on random effects model 
using Jamovi programming software package (V.1.8.1). If 
necessary, sensitivity analysis will be performed to assess 
risk of bias—to identify possible sources of heterogeneity 
(in this case, the analysis will be limited to only included 
studies with low risk of bias). Where appropriate, we 
will conduct subgroup analysis—for example, based on 
gender/sex, design of study or age groupings—to ensure 
that comparable studies are only those that have similar 
effect measures.
However, where there is substantial heterogeneity 
across eligible studies, the three- step approach to 
narrative synthesis would be followed to synthesise the 
evidence drawn from the eligible studies40: ‘(1) organ-
ising the description of the studies into logical categories, 
(2) analysing the findings within each of the categories 
and (3) synthesising the findings across all included 
studies’. Median values and associated IQRs would be 
used to present the prevalence estimates. Also, tables and 
graphical displays (including forest plots) would be used 
to support the narrative synthesis or qualitative summary, 
although meta- analysis would not be performed.40 41 
Where the eligible observational studies (reporting prev-
alence and associations) are sufficient, we will consider 
including only studies that present data as OR and adjust 
for confounding factors (eg, age, sex, etc). However, 
considering that Ghana is now showing potential in 
 on D
ecem









pen: first published as 10.1136/bm






6 Quarshie EN- B, et al. BMJ Open 2021;11:e053144. doi:10.1136/bmjopen-2021-053144
Open access 
contributing published data on self- harm and suicidal 
behaviour, we anticipate including all types of data. The 
exploratory nature of this review and the high possibility 
of accessing a limited number of studies will make the 
inclusion of all types of data useful. Again, the three- step 
approach to narrative synthesis would also be followed 
to synthesise the evidence drawn from the eligible qual-
itative studies (on reported reasons/motivations for and 
means of self- harm and suicidal behaviour).40
Patient and public involvement
No patient involved.
DISCUSSION
When completed, this review will be the first to provide a 
holistic systematic account of the accessible and available 
evidence on the prevalence, correlates, risk and protec-
tive factors, methods and reported reasons for self- harm 
and suicidal behaviour across the general population of 
Ghana. More importantly, we anticipate that evidence 
of this review will, among other things, serve as a useful 
resource contributing to the evidence base informing the 
push for the repeal of the antisuicide law in Ghana.
However, when pooling included studies within a meta- 
analysis, we anticipate the possibility of substantial vari-
ation across records, which may create a challenge for 
meaningful synthesis. This could be due to the broad 
approach guiding this systematic review; but we believe 
that a broad approach affords much value, including 
subgroup analysis exploring the differences and similar-
ities in terms of correlates, risk and protective factors of 
self- harm and suicidal behaviour.
The quality of the evidence reported by eligible studies 
will be assessed, which could be useful for designing 
future research. Potentially, the evidence of this review 
will help in mapping out which domains and (vulnerable) 
groups require self- harm and suicide research atten-
tion; for example, children aged 12 years and younger, 
patients presenting with non- communicable chronic 
medical conditions and persons in correctional facilities. 
Relatedly, the results of this review can inform targeted 
and universal intervention and prevention programmes 
in Ghana. Broadly, we anticipate that this review’s findings 
will be relevant and of interest to persons in academia, 
researchers, the clinical community and health policy-
makers in Ghana.
Amendments
Even though no amendments to the review methods 
described in this protocol are anticipated, in the event of 
necessary protocol amendments, we will provide the date 
of each amendment. Also, we will describe the needed 
change(s) and the rationale in this section (Amend-
ments). Changes will not be included in the protocol. All 
the reviewers will approve all amendment(s). Addition-
ally, any corresponding amendment(s) will be made in 
the PROSPERO registration records of this protocol.
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# Query Hits 
1 attempted suicide.mp. or exp Attempted Suicide/  
2 exp Suicidal Ideation/ or exp Self-Inflicted Wounds/ or exp Attempted Suicide/ or exp Emergency 
Services/ or exp Suicide/ or exp College Students/ or deliberate self-harm.mp. or exp Demographic 
Characteristics/ or exp Self-Destructive Behavior/ or exp Risk Factors/ or exp Self-Injurious Behavior/ 
or exp At Risk Populations/ or exp Epidemiology/ 
 
3 exp Mental Health/ or exp Demographic Characteristics/ or exp Suicidal Ideation/ or exp Major 
Depression/ or exp Suicide Prevention/ or exp Risk Factors/ or exp Suicidality/ or non-fatal suicidal 
behavio?r.mp. or exp Exposure/ or exp Protective Factors/ or exp Suicide/ or exp Self-Injurious 
Behavior/ or exp Attempted Suicide/ or exp Self-Destructive Behavior/ or exp Mental Disorders/ 
 
4 exp Suicide/ or exp Risk Factors/ or exp Self-Destructive Behavior/ or exp Injuries/ or nonsuicidal self-
injury.mp. or exp Suicidal Ideation/ or exp Attempted Suicide/ or exp Self-Injurious Behavior/ 
 
5 exp Attempted Suicide/ or exp Drug Overdoses/ or exp "Death and Dying"/ or overdose.mp.  
6 parasuicide.mp. or exp Attempted Suicide/  
7 self-destructive behavio?r.mp. or exp Self-Destructive Behavior/  
8 exp Attempted Suicide/ or exp Self-Inflicted Wounds/ or exp Suicide/ or self-harm.mp. or exp Suicidal 
Ideation/ or exp Risk Factors/ or exp Self-Destructive Behavior/ or exp Self-Injurious Behavior/ or exp 
Demographic Characteristics/ or exp At Risk Populations/ 
 
9 (suicidal plan* or suicide plan*).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures, mesh] 
 
10 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9  
11 (Accra or Ahafo Region or Ashanti Region or Bolgatanga or Bono East Region or Bono Region or Cape 
Coast or Central Region or Damango or Dambai or Eastern Region or Ghana or Goaso or Greater 
Accra Region or Ho or Koforidua or Kumasi or Nalerigu or North East Region or Northern Region or Oti 
Region or Savannah Region or Sefwi Wiawso or Sekondi or Sunyani or Takoradi or Tamale or 
Techiman or Upper East Region or Upper West Region or Volta Region or Wa or Western North Region 
or Western Region).mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures, mesh] 
 
12 21 and 22  
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